Nanjing Medlander Medical Technology Co. Ltd. A (688273) — Cash Flow Reinvestment Rate
Nanjing Medlander Medical Technology Co. Ltd. A (688273) has a Cash Flow Reinvestment Rate of 3.85x as of December 2024, reinvesting CN¥471.54 Million (capex CN¥129.71 Million plus investments CN¥-341.83 Million) from operating cash flow of CN¥122.51 Million. Explore 688273 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nanjing Medlander Medical Technology Co. Ltd. A Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Nanjing Medlander Medical Technology Co. Ltd. A across 5 annual periods. Also explore 688273 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
Year-by-year capital reinvestment analysis for Nanjing Medlander Medical Technology Co. Ltd. A. For live market cap and broader valuation context, see Nanjing Medlander Medical Technology Co. market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.85x | CN¥471.54 Million | CN¥122.51 Million | CN¥129.71 Million | ▲ +131.6% |
| 2023 | 1.66x | CN¥227.50 Million | CN¥136.91 Million | CN¥75.15 Million | ▲ +49.7% |
| 2022 | 1.11x | CN¥140.57 Million | CN¥126.67 Million | CN¥54.26 Million | ▲ +607.4% |
| 2021 | 0.16x | CN¥23.31 Million | CN¥148.60 Million | CN¥14.58 Million | ▼ -59.2% |
| 2020 | 0.38x | CN¥50.41 Million | CN¥131.10 Million | CN¥25.91 Million | — |